Replimune (REPL) Share-based Compensation (2017 - 2026)
Replimune's Share-based Compensation was $7.67 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 12.4% from $8.76 million a year earlier and down 5.6% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Share-based Compensation (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Replimune's Share-based Compensation was $31.18 million through Jun 30, 2026, down 9.2% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $32.27 million, down 7.9% from FY2025.
- Share-based Compensation shows a five-year compound annual growth rate of 22.3% (FY2021 to FY2026).
- In earlier fiscal years, Share-based Compensation was $35.04 million in FY2025 (+2.7%), $34.13 million in FY2024 (+21.3%), $28.13 million in FY2023 (+16.0%) and $24.25 million in FY2022 (+105.7%).
- Quarterly Share-based Compensation has moved between $5.77 million (fiscal Q4 2022) and $9.48 million (fiscal Q1 2025) over five years.
- Compared with a year earlier, Share-based Compensation has declined for five straight quarters, with an average decline of 5.0% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was fiscal Q2 2022 (growth of 125.4%); the worst was fiscal Q3 2026 (a decline of 18.4%).
- Per Business Quant data, REPL's Share-based Compensation in the three fiscal quarters before Q1 2027 was $8.13 million (Q4 2026), $7.05 million (Q3 2026) and $8.34 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Replimune | 1.05 Bn | 1.05 Bn | - | 7.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.67 Mn |
| Mar 31, 2026 | 8.13 Mn |
| Dec 31, 2025 | 7.05 Mn |
| Sep 30, 2025 | 8.34 Mn |
| Jun 30, 2025 | 8.76 Mn |
| Mar 31, 2025 | 8.28 Mn |
| Dec 31, 2024 | 8.64 Mn |
| Sep 30, 2024 | 8.65 Mn |
| Jun 30, 2024 | 9.48 Mn |
| Mar 31, 2024 | 7.92 Mn |
| Dec 31, 2023 | 8.24 Mn |
| Sep 30, 2023 | 9.12 Mn |
| Jun 30, 2023 | 8.85 Mn |
| Mar 31, 2023 | 6.92 Mn |
| Dec 31, 2022 | 7.02 Mn |
| Sep 30, 2022 | 6.99 Mn |
| Jun 30, 2022 | 7.19 Mn |
| Mar 31, 2022 | 5.77 Mn |
| Dec 31, 2021 | 5.92 Mn |
| Sep 30, 2021 | 6.31 Mn |
API Access
Replimune Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();